Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team will participate in the upcoming investor conferences, detailed below.
- H.C. Wainwright 3rd Annual Immune Cell Engager Virtual Conference
Dates: June 24, 2025 | Virtual
- Wolfe Research Virtual Biotech Day
Dates: June 26, 2025 | Virtual
| Press release in English | 204.32 KB |
| Communiqué de presse en français | 165.49 KB |